rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AUROBINDO PHARMA LTD. - Information Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Download < Back
27 Feb 2021
The Board of Directors of Aurobindo Pharma Limited (&apos;the Company&apos;) at its meeting held today i.e. February 27, 2021, has approved the following:&lt;BR&gt; 1) Transfer of all equity shares held in Lyfius Pharma Private Limited, a wholly owned subsidiary of the Company, to Aurobindo Antibiotics Private Limited, another wholly owned subsidiary of the Company.&lt;BR&gt; 2) Transfer of all equity shares held in Qule Pharma Private Limited, a wholly owned subsidiary of the Company, to Aurobindo Antibiotics Private Limited, another wholly owned subsidiary of the Company.&lt;BR&gt; 3) Transfer of business undertaking comprised in Unit-10, on a going concern basis, to APL Healthcare Limited, a wholly owned subsidiary of the Company. &lt;BR&gt;
View all announcements for AUROBINDO PHARMA LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips